Experimental Induction of Myelin Changes by Anti-MAG Antibodies and Terminal Complement Complex
Salvatore Monaco(University of Verona), Francesco Tedesco(Federico II University Hospital), E. Nardelli(University of Verona), Sérgio Ferrari(University of Verona), Bruno Bonetti(Albert Einstein College of Medicine), Gianluigi Zanusso(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Giuseppe Moretto(University of Verona), MICHAEL KIRSHFINK(Heidelberg University), Nicola Rizzuto(University of Verona), Eduardo Nobile‐Orazio(Humanitas University)
Cited by 52
Related Papers
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
|Nature Communications|2016|294
Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations
|Journal of the Neurological Sciences|2003|258
Pain as a Nonmotor Symptom of Parkinson Disease
|Archives of Neurology|2008|243
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
|Journal of Neurology Neurosurgery & Psychiatry|2020|199
Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and Polyneuropathy
|New England Journal of Medicine|1990|183